OSLO
13F-HR - OSLO PENSJONSFORSIKRING AS (0001828808) (Filer)
Institutional holdings report (13F-HR) for the period ended 2023-06-30 filed by OSLO PENSJONSFORSIKRING AS....
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
FORM
13F-HR - FORM Wealth Advisors, LLC (0002053294) (Filer)
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by FORM Wealth Advisors, LLC....
OSLO
13F-HR - OSLO PENSJONSFORSIKRING AS (0001828808) (Filer)
Institutional holdings report (13F-HR) for the period ended 2023-09-30 filed by OSLO PENSJONSFORSIKRING AS....
OSLO
13F-HR - OSLO PENSJONSFORSIKRING AS (0001828808) (Filer)
Institutional holdings report (13F-HR) for the period ended 2023-12-31 filed by OSLO PENSJONSFORSIKRING AS....
SAB
SAB Bio Receives Fast Track Designation for SAB-142
SAB Biotherapeutics received FDA Fast Track designation for its T1D candidate SAB-142. The designation aims to expedite the review process for the reg...
OSLO
13F-HR - OSLO PENSJONSFORSIKRING AS (0001828808) (Filer)
Institutional holdings report (13F-HR) for the period ended 2024-12-31 filed by OSLO PENSJONSFORSIKRING AS....
Hixon
13F-HR - Hixon Zuercher, LLC (0001806752) (Filer)
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Hixon Zuercher, LLC....
MetaVia
MetaVia Appoints Dr. Sarah Browne as Chief Medical Officer
MetaVia announces Dr. Sarah Browne as Chief Medical Officer to advance its portfolio of cardiometabolic drugs, including Phase 3 candidate DA-1726, st...
OSLO
13F-HR - OSLO PENSJONSFORSIKRING AS (0001828808) (Filer)
Institutional holdings report (13F-HR) for the period ended 2025-03-31 filed by OSLO PENSJONSFORSIKRING AS....
OSLO
13F-HR - OSLO PENSJONSFORSIKRING AS (0001828808) (Filer)
Institutional holdings report (13F-HR) for the period ended 2025-06-30 filed by OSLO PENSJONSFORSIKRING AS....
First
FTK-B Reports 2024 Operational Results
First Tracks Biotherapeutics reported 2024 results highlighting adjusted_cash_flow_of_0_and_a_research_collaboration_agreement_with_Genentech,_marking...
Horizon
Horizon Space enters into deal to acquire ArcheNova
Horizon Space Acquisition I Corp. signed a definitive agreement to acquire ArcheNova Technology Co., Ltd. on October 12, 2026....
Advasa
Advasa sets FY 2031 revenue and profit targets
Advasa Holdings, Inc. announced five-year medium-term operating goals targeting USD 633 million in consolidated revenue and USD 190 million in operati...
Eightco
Eightco Holdings Regains Nasdaq Compliance for Minimum Bid Price
Eightco Holdings Inc. notified Nasdaq that the minimum bid price for its 'ORBS' shares met the $1.00 requirement over the last 10 consecutive business...
True
13F-HR - True Wealth Design, LLC (0001966033) (Filer)
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by True Wealth Design, LLC....
HARBOR
13F-HR - HARBOR INVESTMENT ADVISORY, LLC (0001468792) (Filer)
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by HARBOR INVESTMENT ADVISORY, LLC....
Ipswich
13F-HR - Ipswich Investment Management Co., Inc. (0001463753) (Filer)
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Ipswich Investment Management Co., Inc.....
Berbice
13F-HR - Berbice Capital Management LLC (0002051605) (Filer)
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Berbice Capital Management LLC....
iBio,
iBio data shows IBIO-610 preserves muscle with semaglutide
A non-human primate study found that iBio's candidate IBIO-610 preserved muscle when combined with semaglutide. The company expects to start first-in-...
OSLO
13F-HR - OSLO PENSJONSFORSIKRING AS (0001828808) (Filer)
Institutional holdings report (13F-HR) for the period ended 2025-09-30 filed by OSLO PENSJONSFORSIKRING AS....